Healthium Medtech Expands Surgical Consumables Portfolio with Paramount Surgimed Acquisition

Healthium Medtech has acquired a controlling interest in Paramount Surgimed Ltd., a prominent Indian manufacturer and exporter of surgical blades, scalpels, and dermal biopsy products. The non-surgical segment of Paramount, which includes lifestyle and hygiene businesses, will remain with the Grover family before the transaction is finalised. The financial details of this acquisition have not been disclosed.

Representative image

Paramount Surgimed boasts over 30 years of expertise in specialised manufacturing. It exports more than 95% of its products, serving over 300 OEM and branded customers in more than 100 countries. The company produces over 250 million devices annually and holds international product registrations, including EU MDR and USFDA certifications.

Expansion in Surgical Consumables

The acquisition allows Healthium to strengthen its position in the surgical consumables market. Paramount's expertise in blades and dermal biopsy products complements Healthium's existing business lines. "We see this as an opportunity to align our collective strengths toward a more competitive global position in surgical consumables," stated Anish Bafna, CEO & MD of Healthium Medtech.

Shaily Grover, Managing Director of Paramount Surgimed, expressed optimism about the partnership. "Healthium's operational expertise and established global reach make them an ideal partner for the company's next phase of growth," Grover said. By joining forces, they aim to leverage a larger platform to enhance reliability and market access.

Strategic Partnership for Growth

This strategic acquisition is expected to bolster Healthium's presence in the global market for surgical consumables. By integrating Paramount's manufacturing capabilities and extensive export network, Healthium aims to enhance its competitive edge internationally. The collaboration is set to provide broader resources and an expanded portfolio for both companies.

The partnership between Healthium and Paramount is poised to drive growth by combining their strengths. This move aligns with Healthium's strategy to expand its specialised offerings in the medical devices sector. The collaboration is anticipated to improve market access and product reliability across various regions.

The acquisition marks a significant step for Healthium as it seeks to enhance its global footprint in the medical devices industry. By acquiring Paramount Surgimed, Healthium aims to tap into new markets and strengthen its position in surgical consumables worldwide.

With inputs from PTI